Stopped: This study has been transferred to the Human Research Ethics Committee of St Vincent's Hospital Melbourne.
Hyperspectral retinal imaging is a non-invasive imaging modality in which a series of images of the retina are captured using light of different wavelengths. The resulting "hypercube" of data provides detailed information about retinal structure. Previous research has demonstrated a potential role for this technology in the detection of retinal amyloid beta in Alzheimer's disease. This study aims to further evaluate the use of hyperspectral retinal imaging in the assessment of individuals with dementia or those at risk of Alzheimer's disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Diagnostic performance of hyperspectral retinal imaging for detection of Alzheimer's disease-related beta-amyloid
Timeframe: Single study visit (baseline imaging session; approximately 60 minutes)